Supportive Care Intervention-Pancreas
NCT01885884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2016-05-12
Summary
This is a pilot, randomized controlled trial of an embedded collaborative model of supportive care designed to improve quality of life and decrease use of unwanted healthcare services at the end of life for patients with advanced pancreatic cancer. We will enroll 30 patients who are receiving treatment at the Hillman Cancer Center for recently diagnosed, locally advanced or metastatic pancreatic adenocarcinoma, as well as their accompanying caregivers and providers. Patients will be randomized to receive either the supportive care intervention or usual care. The purpose of this study is to refine an embedded collaborative model of supportive care and to develop protocols for recruitment, randomization, and longitudinal data collection.
Conditions
- Advanced Pancreatic Cancer
Interventions
- BEHAVIORAL
-
Embedded Supportive Care
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Yael Schenker, MD, MAS · University of Pittsburgh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer
NCT01632306 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer
NCT00547612 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas
NCT01783054 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Proton Radiation for Resectable Carcinoma of the Pancreas
NCT00763516 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
NCT05132504 ·Status: RECRUITING ·Phase: PHASE2
-
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
NCT04887805 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Proton Therapy for Unresectable Cancer (CA) of Pancreas
NCT00685763 ·Status: COMPLETED ·Phase: NA
-
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
NCT01240304 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body
NCT02208024 ·Status: COMPLETED ·Phase: NA
-
Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer
NCT01784081 ·Status: WITHDRAWN
-
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
NCT02683824 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
NCT00761345 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
NCT00020345 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer
NCT01025570 ·Status: TERMINATED ·Phase: PHASE1
-
Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
NCT06349278 ·Status: RECRUITING ·Phase: NA
-
Collection of Circulating Biomarkers in Pancreatic Cancer
NCT05743049 ·Status: RECRUITING
-
Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants
NCT00898482 ·Status: COMPLETED
-
Gemcitabine and CT-011 for Resected Pancreatic Cancer
NCT01313416 ·Status: TERMINATED ·Phase: PHASE2
-
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients
NCT05675059 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma
NCT05273554 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Fatigue and Pancreas and Bile Duct Cancer Study
NCT00902759 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer
NCT05438927 ·Status: COMPLETED ·Phase: NA
-
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
NCT01146054 ·Status: COMPLETED ·Phase: PHASE2
-
Diet and Exercise After Pancreatic Cancer
NCT03187028 ·Status: COMPLETED ·Phase: NA
-
Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer
NCT01760694 ·Status: TERMINATED ·Phase: NA